<DOC>
	<DOCNO>NCT01465438</DOCNO>
	<brief_summary>Psoriatic arthritis ( PsA ) inflammatory arthritis associate psoriasis , estimate prevalence 0.3 - 1 % . The clinical course varies , PsA often progressive , erosive arthritis cause severe disability increase mortality . The biologic treatment infliximab etanercept recently introduce treatment PsA psoriasis , current data indicate high efficacy previously available therapy . No clinical trial adalimumab PsA yet publish ( 2005 ) , preliminary data encouraging . The improved treatment option increase need sensitive method diagnosis , monitor prognostication PsA , efficient therapy initiate optimal time point monitor optimally . Ultrasonography ( US ) magnetic resonance imaging ( MRI ) number biomarkers promising , yet sufficiently study , method . The hypothesis adalimumab effective treatment option PsA . Novel imaging- biomarkers provide additional information , compare clinical measure radiography , concern activity , destructive progression prediction therapeutic response PsA patient receive adalimumab . The perspective potential improvement diagnosis , monitor prognostication patient PsA .</brief_summary>
	<brief_title>HUmira Psoriatic Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Psoriatic</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<criteria>Subject Population : patient active PsA , fulfil follow major criterion : 1 . Diagnosis PsA accord Moll Wright criterion ( Moll Wright , 2 . Clinical active disease , define &gt; 2 ( 76 ) swollen joint &gt; 2 ( 78 ) tender joint 3 . Involvement hand ( Clinical swell 1 finger joint and/or 1 1 sausage finger ) 4 . Clinical indication antiTNF alpha therapy , accord treat physician 5 . Among issue : Age &gt; 18 year ; adequate birth control ; contraindication antiTNF alphatherapy , previous antiTNF alphatherapy , significant dermatological disorder psoriasis .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2011</verification_date>
</DOC>